Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-10
DOI
10.1245/s10434-020-08832-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
- (2020) Louis Buscail et al. Nature Reviews Gastroenterology & Hepatology
- Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer
- (2020) Fumiaki Watanabe et al. PLoS One
- Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients
- (2020) He Cheng et al. Cancer Medicine
- Microarray Approach Combined with ddPCR: An Useful Pipeline for the Detection and Quantification of Circulating Tumour dna Mutations
- (2019) Galbiati et al. Cells
- Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
- (2019) Makoto Sugimori et al. CANCER SCIENCE
- Liquid Biopsy im kolorektalen Karzinom
- (2019) A. Haupts et al. PATHOLOGE
- Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival
- (2018) Joel M. Baumgartner et al. ANNALS OF SURGICAL ONCOLOGY
- MutantKRASCirculating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring
- (2018) Ruth Perets et al. ONCOLOGIST
- KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
- (2018) Francesco Sclafani et al. Scientific Reports
- Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
- (2018) Christina Demuth et al. Translational Oncology
- Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue
- (2017) Soichiro Ako et al. PANCREATOLOGY
- Cell-free DNA levels and correlation to stage and outcome following treatment of locally advanced rectal cancer
- (2017) Anders Kindberg Boysen et al. TUMOR BIOLOGY
- Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review
- (2017) Gaowei Fan et al. PLoS One
- Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
- (2016) Naoto Hadano et al. BRITISH JOURNAL OF CANCER
- Detection ofKRASMutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer
- (2016) Nora Brychta et al. CLINICAL CHEMISTRY
- Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial
- (2015) N. Normanno et al. ANNALS OF ONCOLOGY
- Circulating Cell-Free Tumour DNA in the Management of Cancer
- (2015) Glenn Francis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Monitoring gastric cancer progression with circulating tumour DNA
- (2014) T Hamakawa et al. BRITISH JOURNAL OF CANCER
- HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study
- (2014) Katsutoshi Shoda et al. Gastric Cancer
- Changes in mutational status during third-line treatment for metastatic colorectal cancer-Results of consecutive measurement of cell free DNA,KRASandBRAFin the plasma
- (2014) Karen-Lise Garm Spindler et al. INTERNATIONAL JOURNAL OF CANCER
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer
- (2011) Leticia De Mattos-Arruda et al. Future Oncology
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- The intraoperative staging systems in the management of peritoneal surface malignancy
- (2008) A. Gomez Portilla et al. JOURNAL OF SURGICAL ONCOLOGY
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now